Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Some men with early hair loss may have a condition similar to PCOS in women.

Bald men may have higher heart disease risk.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Premature hair greying may indicate a higher risk of metabolic problems.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Olive leaf extract may help reduce aging signs in postmenopausal women.

Women with PCOS in Missan Province have higher weight, hormonal imbalances, and metabolic issues.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Skin tags in severely obese people may indicate higher blood pressure and diabetes risk.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Physical activity, height, and smoking affect prostate cancer risk.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Severe acne patients have higher inflammatory markers than healthy people.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Higher cholesterol levels increase aggressive prostate cancer risk.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.